HCG.. Big ATH Breakout (On the way, for 500% to 1000% returns)

Fundamentally::

- Cheapest across the Hospital Industry, with 18x CFO to EBITDA
- Cancer care is in the great tailwind across developed economies, which makes HCG a good play for the long run. As India evolves into a developed country, or India positions itself as a medical treatment outsourcer.
- CEO is capable of envisioning a turnaround in the business

Technically::

- Highest strength across its industry peers
- Fresh breakout of all-time high, may go 5-10x from this level in 5-7 years.

Disclaimer:: Biased.
#Very_high_Skin_in_the_game!